Published in Neuroscience on May 27, 2009
Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks. J Cereb Blood Flow Metab (2009) 1.97
CCL2/MCP-1 modulation of microglial activation and proliferation. J Neuroinflammation (2011) 1.27
Molecular and cellular neuroinflammatory status of mouse brain after systemic lipopolysaccharide challenge: importance of CCR2/CCL2 signaling. J Neuroinflammation (2014) 1.04
Chemokine CCL2 modulation of neuronal excitability and synaptic transmission in rat hippocampal slices. J Neurochem (2010) 0.98
CRF-amplified neuronal TLR4/MCP-1 signaling regulates alcohol self-administration. Neuropsychopharmacology (2015) 0.93
CCL2 modulates cytokine production in cultured mouse astrocytes. J Neuroinflammation (2010) 0.90
Neuronal CC chemokines: the distinct roles of CCL21 and CCL2 in neuropathic pain. Front Cell Neurosci (2014) 0.88
Help-me signaling: Non-cell autonomous mechanisms of neuroprotection and neurorecovery. Prog Neurobiol (2016) 0.83
ZNF804A Transcriptional Networks in Differentiating Neurons Derived from Induced Pluripotent Stem Cells of Human Origin. PLoS One (2015) 0.83
Stimulatory role of the chemokine CCL2 in the migration and peptide expression of embryonic hypothalamic neurons. J Neurochem (2014) 0.82
Cognitive Status Correlates with CXCL10/IP-10 Levels in Parkinson's Disease. Parkinsons Dis (2014) 0.82
CCL2-ethanol interactions and hippocampal synaptic protein expression in a transgenic mouse model. Front Integr Neurosci (2014) 0.81
MCP-1 and CCR2 gene polymorphisms in Parkinson's disease in a Han Chinese cohort. Neurol Sci (2014) 0.80
Age-dependent effects of kappa-opioid receptor stimulation on cocaine-induced stereotyped behaviors and dopamine overflow in the caudate-putamen: an in vivo microdialysis study. Neuroscience (2010) 0.80
Chronic Intracerebroventricular Infusion of Monocyte Chemoattractant Protein-1 Leads to a Persistent Increase in Sweetened Ethanol Consumption During Operant Self-Administration But Does Not Influence Sucrose Consumption in Long-Evans Rats. Alcohol Clin Exp Res (2015) 0.79
The Chemokine MIP-1α/CCL3 impairs mouse hippocampal synaptic transmission, plasticity and memory. Sci Rep (2015) 0.78
Cecal Ligation and Puncture Results in Long-Term Central Nervous System Myeloid Inflammation. PLoS One (2016) 0.77
Increased astrocyte expression of IL-6 or CCL2 in transgenic mice alters levels of hippocampal and cerebellar proteins. Front Cell Neurosci (2014) 0.76
Persistent adaptation by chronic alcohol is facilitated by neuroimmune activation linked to stress and CRF. Alcohol (2016) 0.76
Cerebral Response to Peripheral Challenge with a Viral Mimetic. Neurochem Res (2015) 0.76
Plasma Chemokines in Patients with Alcohol Use Disorders: Association of CCL11 (Eotaxin-1) with Psychiatric Comorbidity. Front Psychiatry (2017) 0.75
Prenatal fat-rich diet exposure alters responses of embryonic neurons to the chemokine, CCL2, in the hypothalamus. Neuroscience (2016) 0.75
Is there a role for monocyte chemoattractant protein-1 in delirium? Novel observations in elderly hip fracture patients. BMC Res Notes (2015) 0.75
DNA microarray unravels rapid changes in transcriptome of MK-801 treated rat brain. World J Biol Chem (2015) 0.75
Quantitative RT-PCR: limits and accuracy. Biotechniques (1996) 6.88
The melanin-concentrating hormone system of the rat brain: an immuno- and hybridization histochemical characterization. J Comp Neurol (1992) 3.53
Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology. Pharmacol Rev (1993) 2.24
Distribution, cellular localization and functional role of CCR2 chemokine receptors in adult rat brain. J Neurochem (2002) 1.73
Neurotensin and neurotensin receptors. Trends Pharmacol Sci (1999) 1.71
Birth of two chimeric genes in the Hominidae lineage. Science (2001) 1.43
The CCN family: a new class of inflammation modulators? Biochimie (2010) 1.37
Neurotensin: specific binding to synaptic membranes from rat brain. Proc Natl Acad Sci U S A (1977) 1.32
Effects of neurotensin on isolated intestinal smooth muscles. Eur J Pharmacol (1978) 1.23
Activation of phosphatidylinositol turnover by neurotensin receptors in the human colonic adenocarcinoma cell line HT29. FEBS Lett (1986) 1.19
Regulation of amino acid transport in the liver. Emergence of a high affinity transport system in isolated hepatocytes from fasting rats. J Biol Chem (1979) 1.16
Antidepressant-type effects of endogenous enkephalins protected by systemic RB 101 are mediated by opioid delta and dopamine D1 receptor stimulation. Eur J Pharmacol (1992) 1.14
Purification and characterization of a novel neurotensin-degrading peptidase from rat brain synaptic membranes. J Biol Chem (1986) 1.14
Acute and chronic administration of melanin-concentrating hormone enhances food intake and body weight in Wistar and Sprague-Dawley rats. Int J Obes Relat Metab Disord (2002) 1.13
Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist. J Pharmacol Exp Ther (1997) 1.12
Neurotensin binding to extraneural and neural receptors: comparison with biological activity and structure--activity relationships. Mol Pharmacol (1980) 1.10
Isolation of a tridecapeptide from bovine intestinal tissue and its partial characterization as neurotensin. J Biol Chem (1976) 1.09
Delta9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect. Eur J Neurosci (2001) 1.08
Hormonal regulation of apoptosis in breast cells and tissues. Steroids (2000) 1.07
Preparation of a pure monoiodo derivative of the bee venom neurotoxin apamin and its binding properties to rat brain synaptosomes. J Biol Chem (1982) 1.07
No evidence for post-transcriptional control of albumin and alpha-fetoprotein gene expression in developing rat liver neoplasia. Nucleic Acids Res (1982) 1.05
Effects of neurotensin on intestinal smooth muscle: application to the study of structure-activity relationships. Ann N Y Acad Sci (1982) 1.05
The chemokine stromal cell-derived factor-1/CXCL12 activates the nigrostriatal dopamine system. J Neurochem (2007) 1.04
Pharmacology and biochemistry of neurotensin receptors. Rev Clin Basic Pharm (1987) 1.04
Identification of residues involved in neurotensin binding and modeling of the agonist binding site in neurotensin receptor 1. J Biol Chem (2000) 1.03
Detection of rare mRNA species in a complex RNA population by blot hybridization techniques: a comparative survey. Anal Biochem (1983) 1.03
Stromal cell-derived factor-1alpha modulation of the excitability of rat substantia nigra dopaminergic neurones: presynaptic mechanisms. J Neurochem (2006) 1.03
Cellular distribution of neurotensin receptors in rat brain: immunohistochemical study using an antipeptide antibody against the cloned high affinity receptor. J Comp Neurol (1996) 1.02
Nonpeptide antagonists of neuropeptide receptors: tools for research and therapy. Trends Pharmacol Sci (1997) 1.01
Neurotensin stimulates inositol trisphosphate-mediated calcium mobilization but not protein kinase C activation in HT29 cells. Involvement of a G-protein. Biochem J (1989) 1.01
Preparation of neurotensin selectively iodinated on the tyrosine 3 residue. Biological activity and binding properties on mammalian neurotensin receptors. Biochem Biophys Res Commun (1984) 1.00
In vivo and in vitro structure-activity studies with peptide and pseudopeptide neurotensin analogs suggest the existence of distinct central neurotensin receptor subtypes. J Pharmacol Exp Ther (1994) 1.00
Chemokine network in the nervous system: a new target for pain relief. Curr Med Chem (2008) 0.98
The AROM gene, spliced mRNAs encoding new DNA/RNA-binding proteins are transcribed from the opposite strand of the melanin-concentrating hormone gene in mammals. J Biol Chem (2000) 0.98
Dietary supplementation of alpha-linolenic acid in an enriched rapeseed oil diet protects from stroke. Pharmacol Res (2009) 0.98
The amino acid sequence of radioimmunoassayable neurotensin from bovine intestine. J Biol Chem (1978) 0.98
Synthesis and characterization of neurotensin analogues for structure/activity relationship studies. Acetyl-neurotensin-(8--13) is the shortest analogue with full binding and pharmacological activities. Eur J Biochem (1982) 0.98
Identification of the receptor subtype involved in the analgesic effect of neurotensin. J Neurosci (1999) 0.97
Neurotensin metabolism in various tissues of central and peripheral origins: ubiquitous involvement of a novel neurotensin degrading metalloendopeptidase. Biochimie (1988) 0.97
The rat melanin-concentrating hormone gene encodes an additional putative protein in a different reading frame. Endocrinology (1996) 0.96
Distribution of neurotensin binding sites in rat brain: a light microscopic radioautographic study using monoiodo [125I]Tyr3-neurotensin. Neuroscience (1987) 0.96
Neurotensin-mediated inhibition of cyclic AMP formation in neuroblastoma N1E115 cells: involvement of the inhibitory GTP-binding component of adenylate cyclase. Mol Pharmacol (1986) 0.95
Inactivation of neurotensin by rat brain synaptic membranes. Cleavage at the Pro10-Tyr11 bond by endopeptidase 24.11 (enkephalinase) and a peptidase different from proline-endopeptidase. J Neurochem (1984) 0.95
Effect of the nonpeptide neurotensin antagonist, SR 48692, and two enantiomeric analogs, SR 48527 and SR 49711, on neurotensin binding and contractile responses in guinea pig ileum and colon. J Pharmacol Exp Ther (1994) 0.95
The rat alpha-fetoprotein and albumin genes. Transcriptional control and comparison of the sequence organization and promoter region. J Biol Chem (1987) 0.95
Mutational analysis of PC1 (SPC3) in PC12 cells. 66-kDa PC1 is fully functional. J Biol Chem (1995) 0.94
Mutagenesis and modeling of the neurotensin receptor NTR1. Identification of residues that are critical for binding SR 48692, a nonpeptide neurotensin antagonist. J Biol Chem (1998) 0.94
Molecular mechanisms of control of albumin and alphafetoprotein production: a system to study the early effects of chemical hepatocarcinogens. Cell Biol Int Rep (1980) 0.94
Impaired processing of brain proneurotensin and promelanin-concentrating hormone in obese fat/fat mice. Endocrinology (1996) 0.94
Complex effects of stromal cell-derived factor-1 alpha on melanin-concentrating hormone neuron excitability. Eur J Neurosci (2005) 0.94
Insulin and glucagon receptors of isolated rat hepatocytes: comparison between hormone binding and amino acid transport stimulation. Endocrinology (1981) 0.94
Resistance to induced apoptosis in the human neuroblastoma cell line SK-N-SH in relation to neuronal differentiation. Role of Bcl-2 protein family. Eur J Biochem (2001) 0.94
Increased plasma neurotensin concentrations in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry (2001) 0.93
PC5-A-mediated processing of pro-neurotensin in early compartments of the regulated secretory pathway of PC5-transfected PC12 cells. J Biol Chem (1998) 0.92
Specific binding and pharmacological interactions of apamin, the neurotoxin from bee venom, with guinea pig colon. Life Sci (1982) 0.92
NOV/CCN3 upregulates CCL2 and CXCL1 expression in astrocytes through beta1 and beta5 integrins. Glia (2010) 0.92
The nonpeptide neurotensin antagonist, SR 48692, used as a tool to reveal putative neurotensin receptor subtypes. Br J Pharmacol (1994) 0.92
Two populations of neurotensin binding sites in murine brain: discrimination by the antihistamine levocabastine reveals markedly different radioautographic distribution. Eur J Pharmacol (1987) 0.92
Widespread expression of corticotropin-releasing factor messenger RNA and immunoreactivity in the rat olfactory bulb. Brain Res (1989) 0.91
Characterization of neurotensin binding to rat gastric smooth muscle receptor sites. Peptides (1985) 0.90
Distinct functional characteristics of levocabastine sensitive rat neurotensin NT2 receptor expressed in Chinese hamster ovary cells. Life Sci (1998) 0.90
Inactivation of neurotensin by rat brain synaptic membranes partly occurs through cleavage at the Arg8-Arg9 peptide bond by a metalloendopeptidase. J Neurochem (1985) 0.90
Pro-melanin concentrating hormone messenger ribonucleic acid and peptides expression in peripheral tissues of the rat. Neuroendocrinology (1995) 0.90
Regulation of cyclic GMP levels by neurotensin in neuroblastoma clone N1E115. Biochem Biophys Res Commun (1985) 0.90
Automated keratoconus detection using the EyeSys videokeratoscope. J Cataract Refract Surg (2000) 0.90
Neuromedin-N is not released with neurotensin from rat ileum. Endocrinology (1990) 0.89
Rat hippocampal neurons are critically involved in physiological improvement of memory processes induced by cholecystokinin-B receptor stimulation. J Neurosci (1999) 0.89
Differential DNase I sensitivity of the albumin and alpha-fetoprotein genes in chromatin from rat tissues and cell lines. Proc Natl Acad Sci U S A (1984) 0.89
Correlative ultrastructural distribution of neurotensin receptor proteins and binding sites in the rat substantia nigra. J Neurosci (1998) 0.88
Similarities in cellular expression and functions of melanin-concentrating hormone and atrial natriuretic factor in the rat digestive tract. Endocrinology (1996) 0.88
Stimulation of inositol phosphate production by neurotensin in neuroblastoma N1E115 cells: implication of GTP-binding proteins and relationship with the cyclic GMP response. J Neurochem (1987) 0.88
Neurotensin is a potent inhibitor of guinea-pig colon contractile activity. Eur J Pharmacol (1981) 0.88
Molecular properties of neurotensin receptors in rat brain. Identification of subunits by covalent labeling. J Biol Chem (1985) 0.88
Melanin-concentrating hormone is a potent anorectic peptide regulated by food-deprivation and glucopenia in the rat. Neuroscience (1996) 0.87
Assignment of the human pro-melanin-concentrating hormone gene (PMCH) to chromosome 12q23-q24 and two variant genes (PMCH1 and PMCHL2) to chromosome 5p14 and 5q12-q13. Genomics (1994) 0.87
Cellular localization and role of prohormone convertases in the processing of pro-melanin concentrating hormone in mammals. J Biol Chem (1999) 0.87
[3H]SR 48692, the first nonpeptide neurotensin antagonist radioligand: characterization of binding properties and evidence for distinct agonist and antagonist binding domains on the rat neurotensin receptor. Mol Pharmacol (1995) 0.87
Specific sets of DNase I-hypersensitive sites are associated with the potential and overt expression of the rat albumin and alpha-fetoprotein genes. Proc Natl Acad Sci U S A (1987) 0.87
Neurotensin agonist induces differential regulation of neurotensin receptor mRNA. Identification of distinct transcriptional and post-transcriptional mechanisms. J Biol Chem (1997) 0.87
Parallel secretion of endogenous 5-hydroxytryptamine and histamine from mast cells stimulated by vasoactive peptides and compound 48/80. Br J Pharmacol (1984) 0.87
Albumin and alpha-fetoprotein gene transcription in rat hepatoma cell lines is correlated with specific DNA hypomethylation and altered chromatin structure in the 5' region. Mol Cell Biol (1987) 0.87
Agonism, inverse agonism, and neutral antagonism at the constitutively active human neurotensin receptor 2. Mol Pharmacol (2001) 0.86
Baicalein protects cortical neurons from beta-amyloid (25-35) induced toxicity. Neuroreport (2001) 0.86
Evidence that PC2 is the endogenous pro-neurotensin convertase in rMTC 6-23 cells and that PC1- and PC2-transfected PC12 cells differentially process pro-neurotensin. J Biol Chem (1996) 0.86
Degradation of neurotensin by rat brain synaptic membranes: involvement of a thermolysin-like metalloendopeptidase (enkephalinase), angiotensin-converting enzyme, and other unidentified peptidases. J Neurochem (1983) 0.86
Structure of the human melanin concentrating hormone mRNA. Mol Endocrinol (1990) 0.86
A new neuroregulator: the vasoactive intestinal peptide or VIP. Mol Cell Endocrinol (1982) 0.85
The role of dibasic residues in prohormone sorting to the regulated secretory pathway. A study with proneurotensin. J Biol Chem (2000) 0.85